The doors of precision: Reenergizing psychiatric drug development with psychedelics and open access computational tools.
Daniel S. Barron, Richard A. Friedman
Science Advances March 16, 2022 DOI: 10.1126/sciadv.abp8283 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Citations | 5 |
Abstract
Psychedelics paired with new applications of computational tools might help bypass the imprecision of psychiatric diagnosis and connect measures of behavior to specific physiologic targets.